Tructyre chief executive officer Glenn Sherwood has announced the launch of Tyrewatch, a predictive tyre management system the company states can “prevent 95 per cent of tyre related breakdowns”, from The Satellite Applications Catapult in Harlow, near Oxford, an organisation which has assisted the project in implementing satellite communications connectivity. The new system for fleets, three-plus years in development for its initial phase, combines tyre pressure monitoring systems (TPMS) with increased and continuous cellular and satellite connectivity and artificial intelligence to provide automated analysis of fleets’ tyres. The system works by connecting sensors continuously monitoring tyre pressure, temperature, vehicle speed and GPS location to TyreWatch’s servers, which in turn alerts drivers, fleet managers, and tyre servicing providers where action should be taken. All of this results in a trio of potential benefits: economic, safety, and a step towards autonomy for logistics vehicles.
A consortium initiated by Tructyre has won £1.2 million of funding for its “Pathway to Autonomous Commercial Vehicles” project. This project aims to develop “an innovative solution to monitor key information from the vehicle and predict safety risks based on analytics”. It builds on a prototype which monitors tyre pressures and temperatures in commercial vehicles, combined with always-on network connection.
Eight projects have been awarded a total of £20 million in funding to research and develop enhanced communication between vehicles and roadside infrastructure or urban information systems, including new ‘talking car technologies’, Business Secretary Sajid Javid announced on a visit to the autonomous vehicles test bed at MIRA in Nuneaton on 1 February 2016.
The projects are the first to be funded from the government’s £100 million Intelligent Mobility Fund. They range from developing autonomous shuttles to carry visually-impaired passengers using advanced sensors and control systems, to new simulation trials for autonomous pods to increase uptake and improve real-world trials.